Skip Navigation

EpiPen rival making a comeback

In this video

MYL

EpiPen rival making a comeback

CNBC's Meg Tirrell reports on the return of EpiPen's rival, Kaleo's Auvi-Q.

02:36

Wed, Oct 26 20163:43 PM EDT

Earnings will make new record highs over the next few quarters, says Ed Yardeni

Earnings will make new record highs over the next few quarters, says Ed Yardeni

6 hours ago

Charles Schwab's Kevin Gordon: More weakness in the labor market needs to happen for a Fed cut

Charles Schwab's Kevin Gordon: More weakness in the labor market needs to happen for a Fed cut

6 hours ago

Google's fate hinges on this man: Demis Hassabis

Google's fate hinges on this man: Demis Hassabis

6 hours ago

Austin Ekeler on joining the Washington Commanders

Austin Ekeler on joining the Washington Commanders

The Fed on rate cut timeline, restrictive monetary policy and inflation target

The Fed on rate cut timeline, restrictive monetary policy and inflation target

Earnings will make new record highs over the next few quarters, says Ed Yardeni

Earnings will make new record highs over the next few quarters, says Ed Yardeni

6 hours ago

Charles Schwab's Kevin Gordon: More weakness in the labor market needs to happen for a Fed cut

Charles Schwab's Kevin Gordon: More weakness in the labor market needs to happen for a Fed cut

6 hours ago

Google's fate hinges on this man: Demis Hassabis

Google's fate hinges on this man: Demis Hassabis

6 hours ago

Austin Ekeler on joining the Washington Commanders

Austin Ekeler on joining the Washington Commanders

The Fed on rate cut timeline, restrictive monetary policy and inflation target

The Fed on rate cut timeline, restrictive monetary policy and inflation target